CADRE HOLDINGS INC (CDRE) Fundamental Analysis & Valuation

NYSE:CDRE • US12763L1052

Current stock price

31.65 USD
-0.3 (-0.94%)
At close:
32.96 USD
+1.31 (+4.14%)
After Hours:

This CDRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CDRE Profitability Analysis

1.1 Basic Checks

  • CDRE had positive earnings in the past year.
  • In the past year CDRE had a positive cash flow from operations.
  • Each year in the past 5 years CDRE has been profitable.
  • In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.73%, CDRE is in the better half of the industry, outperforming 70.51% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.89%, CDRE is in the better half of the industry, outperforming 75.64% of the companies in the same industry.
  • CDRE has a Return On Invested Capital of 7.75%. This is in the better half of the industry: CDRE outperforms 65.38% of its industry peers.
  • CDRE had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 9.32%.
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROIC 7.75%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

1.3 Margins

  • CDRE's Profit Margin of 7.23% is fine compared to the rest of the industry. CDRE outperforms 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of CDRE has declined.
  • CDRE's Operating Margin of 12.30% is fine compared to the rest of the industry. CDRE outperforms 74.36% of its industry peers.
  • In the last couple of years the Operating Margin of CDRE has declined.
  • The Gross Margin of CDRE (42.54%) is better than 80.77% of its industry peers.
  • CDRE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. CDRE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CDRE is destroying value.
  • CDRE has more shares outstanding than it did 1 year ago.
  • CDRE has more shares outstanding than it did 5 years ago.
  • CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • CDRE has an Altman-Z score of 3.29. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 3.29, CDRE perfoms like the industry average, outperforming 47.44% of the companies in the same industry.
  • CDRE has a debt to FCF ratio of 5.45. This is a neutral value as CDRE would need 5.45 years to pay back of all of its debts.
  • CDRE's Debt to FCF ratio of 5.45 is fine compared to the rest of the industry. CDRE outperforms 70.51% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that CDRE is somewhat dependend on debt financing.
  • CDRE's Debt to Equity ratio of 0.92 is on the low side compared to the rest of the industry. CDRE is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Altman-Z 3.29
ROIC/WACC0.8
WACC9.71%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • CDRE has a Current Ratio of 3.50. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
  • CDRE has a Current ratio of 3.50. This is in the better half of the industry: CDRE outperforms 64.10% of its industry peers.
  • A Quick Ratio of 2.54 indicates that CDRE has no problem at all paying its short term obligations.
  • CDRE has a better Quick ratio (2.54) than 70.51% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 2.54
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

6

3. CDRE Growth Analysis

3.1 Past

  • CDRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.37%, which is quite good.
  • The Earnings Per Share has been decreasing by -1.75% on average over the past years.
  • Looking at the last year, CDRE shows a small growth in Revenue. The Revenue has grown by 7.53% in the last year.
  • CDRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.57% yearly.
EPS 1Y (TTM)14.37%
EPS 3Y85.2%
EPS 5Y-1.75%
EPS Q2Q%-27.14%
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%

3.2 Future

  • CDRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.91% yearly.
  • The Revenue is expected to grow by 10.09% on average over the next years. This is quite good.
EPS Next Y21.93%
EPS Next 2Y15.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.41%
Revenue Next 2Y10.3%
Revenue Next 3Y10.09%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. CDRE Valuation Analysis

4.1 Price/Earnings Ratio

  • CDRE is valuated quite expensively with a Price/Earnings ratio of 31.03.
  • 74.36% of the companies in the same industry are more expensive than CDRE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.71. CDRE is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 21.14, which indicates a rather expensive current valuation of CDRE.
  • CDRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CDRE is cheaper than 87.18% of the companies in the same industry.
  • CDRE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.03
Fwd PE 21.14
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 82.05% of the companies in the same industry are more expensive than CDRE, based on the Enterprise Value to EBITDA ratio.
  • 92.31% of the companies in the same industry are more expensive than CDRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.64
EV/EBITDA 15.73
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • CDRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CDRE may justify a higher PE ratio.
  • A more expensive valuation may be justified as CDRE's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3YN/A

4

5. CDRE Dividend Analysis

5.1 Amount

  • CDRE has a Yearly Dividend Yield of 1.26%.
  • In the last 3 months the price of CDRE has falen by -27.61%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • CDRE's Dividend Yield is rather good when compared to the industry average which is at 0.65. CDRE pays more dividend than 87.18% of the companies in the same industry.
  • CDRE's Dividend Yield is slightly below the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

  • CDRE has been paying a dividend for over 5 years, so it has already some track record.
  • CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • CDRE pays out 35.00% of its income as dividend. This is a sustainable payout ratio.
DP35%
EPS Next 2Y15.91%
EPS Next 3YN/A
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CDRE Fundamentals: All Metrics, Ratios and Statistics

CADRE HOLDINGS INC

NYSE:CDRE (3/13/2026, 8:14:30 PM)

After market: 32.96 +1.31 (+4.14%)

31.65

-0.3 (-0.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-11
Earnings (Next)05-04
Inst Owners80.08%
Inst Owner Change6.94%
Ins Owners28.59%
Ins Owner Change-0.52%
Market Cap1.29B
Revenue(TTM)610.31M
Net Income(TTM)44.14M
Analysts80
Price Target50.32 (58.99%)
Short Float %5.73%
Short Ratio8.3
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.37
Dividend Growth(5Y)N/A
DP35%
Div Incr Years1
Div Non Decr Years3
Ex-Date01-30
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.82%
Min Revenue beat(2)-10.38%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-10.38%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-2.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.99%
Revenue beat(16)11
Avg Revenue beat(16)-0.01%
PT rev (1m)1.37%
PT rev (3m)1.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.55%
EPS NY rev (1m)0.84%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 31.03
Fwd PE 21.14
P/S 2.11
P/FCF 22.64
P/OCF 20.2
P/B 4.05
P/tB 60.1
EV/EBITDA 15.73
EPS(TTM)1.02
EY3.22%
EPS(NY)1.5
Fwd EY4.73%
FCF(TTM)1.4
FCFY4.42%
OCF(TTM)1.57
OCFY4.95%
SpS15.01
BVpS7.82
TBVpS0.53
PEG (NY)1.42
PEG (5Y)N/A
Graham Number13.39
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROCE 11.28%
ROIC 7.75%
ROICexc 9.51%
ROICexgc 20.95%
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
FCFM 9.31%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
ROICexc(3y)12.43%
ROICexc(5y)12.27%
ROICexgc(3y)27.27%
ROICexgc(5y)26.53%
ROCE(3y)13.93%
ROCE(5y)14.36%
ROICexgc growth 3Y25.09%
ROICexgc growth 5Y-11.22%
ROICexc growth 3Y20.63%
ROICexc growth 5Y-11.53%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Debt/EBITDA 3.13
Cap/Depr 36.79%
Cap/Sales 1.12%
Interest Coverage 4.21
Cash Conversion 68%
Profit Quality 128.79%
Current Ratio 3.5
Quick Ratio 2.54
Altman-Z 3.29
F-Score6
WACC9.71%
ROIC/WACC0.8
Cap/Depr(3y)38.02%
Cap/Depr(5y)32.68%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.03%
Profit Quality(3y)124.37%
Profit Quality(5y)277.85%
High Growth Momentum
Growth
EPS 1Y (TTM)14.37%
EPS 3Y85.2%
EPS 5Y-1.75%
EPS Q2Q%-27.14%
EPS Next Y21.93%
EPS Next 2Y15.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%
Revenue Next Year16.41%
Revenue Next 2Y10.3%
Revenue Next 3Y10.09%
Revenue Next 5YN/A
EBIT growth 1Y3.13%
EBIT growth 3Y52.65%
EBIT growth 5Y6.18%
EBIT Next Year87.72%
EBIT Next 3Y33.16%
EBIT Next 5YN/A
FCF growth 1Y117.74%
FCF growth 3Y10.69%
FCF growth 5Y6.91%
OCF growth 1Y100.48%
OCF growth 3Y11.14%
OCF growth 5Y7%

CADRE HOLDINGS INC / CDRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CDRE.


What is the valuation status of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


Can you provide the profitability details for CADRE HOLDINGS INC?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 6 / 10.


How financially healthy is CADRE HOLDINGS INC?

The financial health rating of CADRE HOLDINGS INC (CDRE) is 5 / 10.


Can you provide the expected EPS growth for CDRE stock?

The Earnings per Share (EPS) of CADRE HOLDINGS INC (CDRE) is expected to grow by 21.93% in the next year.